Call For More PET Tech Assessment Studies To Shape CMS Coverage Debate
This article was originally published in The Gray Sheet
Executive Summary
Preliminary evidence bodes well for positron emission tomography (PET) to be used as an adjunct in initially diagnosing cervical, ovarian, pancreatic, small-cell lung and testicular cancers, but further confirmatory studies are needed, according to AHRQ